Scientists at the Salk Institute labs in San Diego have come up with the preliminary evidence that tetrahydrocannabinol (THC) and other compounds that cannabis part can eliminate amyloid beta, the toxic protein generally associated with Alzheimer’s disease.
The Salk Institute officials have warned that the findings published in the journal Aging and Mechanisms of Disease’s June issue mustn’t be taken as an indication that cannabis is a cure for Alzheimer’s.
They carried out the studies in neurons grown in a lab, and the studies could ultimately offer insight in the part inflammation plays in the disease. The work of Salk Institute may offer indications regarding creating novel therapeutics for the disorder.
The study’s senior author, David Schubert, said, “Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s. We believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells”.
Read more
